If you have a patient with pyoderma gangrenosum (PG), tell them about the Boehringer Ingelheim(BI) PG registry being conducted by United BioSource, LLC.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Thank you, to all the wound care practitioners who work hard to identify and find treatment for these patients!

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Every practitioner using these products is going to deal with one or more Medicare auditors.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

It is unfortunate that an opportunity to understand the impact of Semaglutide on diabetic foot ulcers was entirely lost.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Here’s a guest blog from Michael Crouch, following up on Martha Kelso’s post about audit requirements.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Lives are at stake, so let us never relax in our commitment to safety and excellence in the practice of Hyperbaric Medicine.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Check out Knicole Emanuel’s recent blog post about CMS monetary recoupment before full adjudication.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

A heads-up about the documentation demands for a recent audit of CTPs/CAMPs/skin substitutes – this time a UPIC audit.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Check out Jeanne Pinder’s newest Clear Health Costs article about the “skin substitute” market.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

An article in JAMA Dermatology reviews the wound characteristics of a series of 29 patients hospitalized with confirmed xylazine exposure.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.